Showing 6891-6900 of 18626 results for "".
Mental Health Support for COVID-19 Healthcare Workers
https://reachmd.com/programs/public-health-call/mental-health-support-for-covid-19-healthcare-workers/11368/In the midst of a pandemic, resilience is key for healthcare workers.What is the POSEIDON Classification?
https://reachmd.com/programs/global-womens-health-academy/what-is-the-poseidon-classification/9878/Dr. Humaidan discusses the POSEIDON classification and an overview of how it is utilized in clinical management.Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
https://evolvemeded.com/specialty/optometry/antibody-drug-conjugates-insights-and-challenges-in-oncology-and-ophthalmology-2421/32347/Ocular oncology specialists summarize a treatment regimen to effectively manage ocular toxicities associated with antibody-drug conjugates.Trial in Progress: Phase 3 MoonRISe-3 Study
https://reachmd.com/clinical-practice/oncology-hematology/trial-in-progress-phase-3-moonrise-3-study/33214/Dr. Neal Shore discusses the study design of the phase 3 MoonRISe-3 trial of TAR-210 in BCG-treated high-risk NMIBC with susceptible FGFR alterations.Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
https://reachmd.com/programs/cme/titrating-and-dosing-device-therapy-for-dre-best-practices-for-optimizing-patient-outcomes/14854/How do you titrate & dose a patient on VNS therapy? Experts discuss best practices in adult & pediatric patients with add-on neuromodulation for DRE.Community Clinic: Translating Data Into Action ─ Practical Strategies for Optimizing First-Line RCC Management
https://reachmd.com/programs/cme/Community-Clinic-Translating-Data-Into-Action-Practical-Strategies-for-Optimizing-First-Line-RCC-Management/35774/Learn to apply evidence-based strategies to guide first-line therapy selection and manage treatment-related adverse events in advanced renal cell carcinomaTargeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
https://reachmd.com/programs/cme/targeting-the-fc-receptor-pathway-to-treat-red-blood-cell-alloimmunization/13908/Delve deeper into the basic biology and functions of the FcRn receptor. Could it be the key to solving the clinical conundrum of HDFN?Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
https://reachmd.com/programs/cme/optimizing-the-role-for-corticosteroids-within-the-evolving-dmd-treatment-landscape/37232/Navigate corticosteroid use in DMD: Compare options, manage side effects, and align treatment with advanced therapies.From Pathway to Patient: Clinical Advances in PI3K-Directed Therapy for HR+/HER2- mBC
https://reachmd.com/programs/cme/From-Pathway-to-Patient-Clinical-Advances-in-PI3K-Directed-Therapy-for-HR-HER2-mBC/35975/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Managing Travel With PAH: Logistics, Medications, Oxygen, and Emergency Preparedness
https://reachmd.com/programs/cme/managing-travel-with-pah-logistics-medications-oxygen-and-emergency-preparedness/33237/Learn about applying patient-centered approaches in the management of pulmonary arterial hypertension (PAH) to optimize patient outcomes.